Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Fujioka

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|January 24, 2007
Pharmacologic treatment options for obesity: current and potential medicationsKen Fujioka, Michael W Lee
The Journal of Family Practice|August 28, 2016
Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic ManagementKen Fujioka, Jill Braverman-Panza
Expert Opinion on Pharmacotherapy|June 23, 2009
Naltrexone for the treatment of obesity: review and updateMichael William Lee, Ken Fujioka
Endocrinology and Metabolism Clinics of North America|May 19, 2020
Barriers and Solutions for Prescribing Obesity PharmacotherapyKen Fujioka, Samantha R Harris
American Journal of Therapeutics|May 12, 2010
Vomiting from multivitamins: a potential drug interactionFrank Greenway, Ken Fujioka, Ying Yu
Clinical Therapeutics|May 17, 2003
Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulationKen Fujioka, Miranda Pans, Steven Joyal
Obesity Surgery|July 10, 2010
Do gastric bypass patient characteristics, behavior, and health differ depending upon how successful weight loss is defined?Karen J Coleman, Ruzbeh Toussi, Ken Fujioka
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 8, 2021
Binge-Eating Disorder and Type 2 Diabetes: A ReviewSamantha R Harris, Maritza Carrillo, Ken Fujioka
Drugs|May 13, 2015
Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory DivideAndrew J Krentz, Ken Fujioka, Marcus Hompesch
Obesity (Silver Spring, Md.)|January 24, 2009
Pre- and postsurgery behavioral compliance, patient health, and postbariatric surgical weight lossRuzbeh Toussi, Ken Fujioka, Karen J Coleman
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|January 24, 2007
Pharmacologic treatment options for obesity: current and potential medicationsKen Fujioka, Michael W Lee
The Journal of Family Practice|August 28, 2016
Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic ManagementKen Fujioka, Jill Braverman-Panza
Expert Opinion on Pharmacotherapy|June 23, 2009
Naltrexone for the treatment of obesity: review and updateMichael William Lee, Ken Fujioka
Endocrinology and Metabolism Clinics of North America|May 19, 2020
Barriers and Solutions for Prescribing Obesity PharmacotherapyKen Fujioka, Samantha R Harris
American Journal of Therapeutics|May 12, 2010
Vomiting from multivitamins: a potential drug interactionFrank Greenway, Ken Fujioka, Ying Yu
Clinical Therapeutics|May 17, 2003
Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulationKen Fujioka, Miranda Pans, Steven Joyal
Obesity Surgery|July 10, 2010
Do gastric bypass patient characteristics, behavior, and health differ depending upon how successful weight loss is defined?Karen J Coleman, Ruzbeh Toussi, Ken Fujioka
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 8, 2021
Binge-Eating Disorder and Type 2 Diabetes: A ReviewSamantha R Harris, Maritza Carrillo, Ken Fujioka
Drugs|May 13, 2015
Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory DivideAndrew J Krentz, Ken Fujioka, Marcus Hompesch
Obesity (Silver Spring, Md.)|January 24, 2009
Pre- and postsurgery behavioral compliance, patient health, and postbariatric surgical weight lossRuzbeh Toussi, Ken Fujioka, Karen J Coleman
Pageof 7